CLINICAL_TRIALS ClinicalTrials.gov record update

A Cancer Research UK Phase I/IIa Trial of HTL0039732, Given Orally as Monotherapy and in Combination With Immunotherapy or Other Approved Therapies in Participants With Advanced Solid Tumours

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05944237
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:42.672975+00:00
Published At: 2025-06-08T00:00:00+00:00
Record Updated At: 2025-06-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neoplasms", "Prostatic Neoplasms, Castration-Resistant", "Stomach Neoplasms", "Esophageal Neoplasms", "Head and Neck Neoplasms", "Colorectal Neoplasms", "Pancreatic Neoplasms", "Lung Neoplasms", "Urinary Bladder Neoplasms", "Mesothelioma, Malignant", "Uterine Cervical Neoplasms", "Kidney Neoplasms", "Sarcoma", "Pheochromocytomas"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-06-08"
protocolSection.identificationModule.nctId: "NCT05944237"
protocolSection.identificationModule.officialTitle: "A Cancer Research UK Phase I/IIa Trial of HTL0039732, Given Orally as Monotherapy and in Combination With Immunotherapy or Other Approved Therapies in Participants With Advanced Solid Tumours"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.